Breakthrough breast cancer drug 'too expensive'

Breakthrough breast cancer drug 'too expensive': A breast cancer drug described as the biggest advance in almost 20 years has been rejected by the Government's rationing watchdog as too expensive. The Daily Telegraph

See also:

• Breast cancer drug does not provide value for money, regulator rules The Guardian
• Breast cancer treatment not value for money says draft NICE guidance NICE